发明名称 VACCINE COMPOSITION
摘要 <p><P>PROBLEM TO BE SOLVED: To solve the problem that production of a multi-valent vaccine is required. <P>SOLUTION: A multi-valent immunogenic composition for imparting protection against diseases caused by Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Hepatitis B virus, poliovirus or Neisseria meningitidis to a host, is provided, which composition comprises (a) either killed whole-cell Bordetella pertussis (Pw), or two or more acellular pertussis components (Pa) (preferably the latter), (b) tetanus toxoid (TT or T), (c) diphtheria toxoid (DT or D), (d) Hepatitis B surface antigen (HepB or HB), (e) inactivated poliovirus (IPV), (f) one or both conjugates of a carrier protein and a capsular polysaccharide of bacterium selected from the group consisting of Neisseria meningitidis Y and Neisseria meningitidis C (MenY and MenC), and (g) optionally a conjugate of a carrier protein and the capsular polysaccharide of Haemophilus influenzae B (Hib). <P>COPYRIGHT: (C)2009,JPO&INPIT</p>
申请公布号 JP2009102355(A) 申请公布日期 2009.05.14
申请号 JP20080320381 申请日期 2008.12.17
申请人 GLAXOSMITHKLINE BIOLOGICALS SA 发明人 BOUTRIAU DOMINIQUE;CAPIAU CARINE;DESMONS PIERRE MICHEL;LEMOINE DOMINIQUE;POOLMAN JAN
分类号 A61K39/05;A61K39/08;A61K39/09;A61K39/095;A61K39/10;A61K39/102;A61K39/116;A61K39/13;A61K39/29;A61K39/295;A61K39/39;A61K47/02;A61P31/04;A61P31/12;A61P31/14;A61P31/16;A61P31/20;A61P43/00 主分类号 A61K39/05
代理机构 代理人
主权项
地址